Valuation Update With 7 Day Price Move • May 18
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩180,200, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 115% over the past three years. Reported Earnings • Mar 24
Full year 2025 earnings: EPS exceeds analyst expectations Full year 2025 results: EPS: ₩10,847 (up from ₩7,562 in FY 2024). Revenue: ₩2.40t (up 11% from FY 2024). Net income: ₩123.1b (up 43% from FY 2024). Profit margin: 5.1% (up from 4.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 95%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩198,700, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 157% over the past three years. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩160,700, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 102% over the past three years. Tillkännagivande • Feb 23
Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl. Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl on February 23, 2026. Through this acquisition, COSMAX seeks to leverage the strengths of both companies to create significant synergies.
For the period ending December 31, 2025, Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl reported total revenue of €10.5 million.
COSMAX plans to satisfy the conditions precedent, including securing approval from the Italian government, by March, to finalize the transaction. Major Estimate Revision • Jan 27
Consensus EPS estimates fall by 16% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩6,824 to ₩5,749 per share. Revenue forecast steady at ₩2.40b. Net income forecast to grow 149% next year vs 61% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩242,500. Share price rose 2.9% to ₩189,600 over the past week. Reported Earnings • Nov 19
Third quarter 2025 earnings: EPS and revenues miss analyst expectations Third quarter 2025 results: EPS: ₩789 (down from ₩1,856 in 3Q 2024). Revenue: ₩585.6b (up 11% from 3Q 2024). Net income: ₩8.96b (down 57% from 3Q 2024). Profit margin: 1.5% (down from 4.0% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 76%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Nov 12
Price target decreased by 10% to ₩256,280 Down from ₩285,600, the current price target is an average from 25 analysts. New target price is 62% above last closing price of ₩158,000. Stock is up 19% over the past year. The company is forecast to post earnings per share of ₩6,484 for next year compared to ₩7,562 last year. Major Estimate Revision • Nov 11
Consensus EPS estimates fall by 28% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩9,309 to ₩6,713 per share. Revenue forecast steady at ₩2.45b. Net income forecast to grow 92% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩280,160. Share price fell 22% to ₩156,500 over the past week. New Risk • Aug 19
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.6% operating cash flow to total debt). High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Reported Earnings • Aug 19
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: EPS: ₩1,844 (down from ₩2,965 in 2Q 2024). Revenue: ₩623.6b (up 13% from 2Q 2024). Net income: ₩20.9b (down 38% from 2Q 2024). Profit margin: 3.4% (down from 6.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth. Major Estimate Revision • Aug 13
Consensus EPS estimates fall by 10% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩2.55b to ₩2.52b. EPS estimate also fell from ₩11,353 per share to ₩10,172 per share. Net income forecast to grow 67% next year vs 32% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩295,167 to ₩288,000. Share price fell 25% to ₩191,600 over the past week. Valuation Update With 7 Day Price Move • Aug 12
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₩196,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 188% over the past three years. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩278,500, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩393,577 per share. Price Target Changed • Jun 18
Price target increased by 9.5% to ₩261,571 Up from ₩238,952, the current price target is an average from 21 analysts. New target price is approximately in line with last closing price of ₩262,000. Stock is up 40% over the past year. The company is forecast to post earnings per share of ₩11,419 for next year compared to ₩7,562 last year. Price Target Changed • May 19
Price target increased by 7.1% to ₩227,714 Up from ₩212,667, the current price target is an average from 21 analysts. New target price is 11% above last closing price of ₩205,000. Stock is up 24% over the past year. The company is forecast to post earnings per share of ₩11,055 for next year compared to ₩7,562 last year. Valuation Update With 7 Day Price Move • May 14
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩214,000, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 244% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩424,696 per share. New Risk • Mar 23
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows. Reported Earnings • Mar 21
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: EPS: ₩7,562 (up from ₩5,036 in FY 2023). Revenue: ₩2.17t (up 22% from FY 2023). Net income: ₩85.8b (up 50% from FY 2023). Profit margin: 4.0% (up from 3.2% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Mar 06
Cosmax, Inc., Annual General Meeting, Mar 27, 2025 Cosmax, Inc., Annual General Meeting, Mar 27, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 46, jeyak gongdan2-gil, hyangnam-eup, gyeonggi-do, hwaseong South Korea Price Target Changed • Mar 04
Price target increased by 7.5% to ₩208,300 Up from ₩193,789, the current price target is an average from 20 analysts. New target price is 25% above last closing price of ₩166,100. Stock is up 58% over the past year. The company is forecast to post earnings per share of ₩8,488 for next year compared to ₩5,036 last year. Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩153,900, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,839 per share. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩145,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 21% over the past three years. Price Target Changed • Aug 31
Price target decreased by 8.0% to ₩187,625 Down from ₩204,000, the current price target is an average from 16 analysts. New target price is 55% above last closing price of ₩121,300. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩9,550 for next year compared to ₩5,036 last year. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩128,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 7.0% over the past three years. New Risk • Jul 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (61% net debt to equity). Share price has been volatile over the past 3 months (7.6% average weekly change). Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩147,700, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,767 per share. Price Target Changed • Jul 17
Price target increased by 7.6% to ₩213,000 Up from ₩198,000, the current price target is an average from 16 analysts. New target price is 20% above last closing price of ₩178,200. Stock is up 87% over the past year. The company is forecast to post earnings per share of ₩10,778 for next year compared to ₩5,036 last year. Buy Or Sell Opportunity • Jul 01
Now 24% undervalued Over the last 90 days, the stock has risen 48% to ₩189,100. The fair value is estimated to be ₩250,445, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 118% in the next 2 years. Buy Or Sell Opportunity • Jun 20
Now 24% undervalued Over the last 90 days, the stock has risen 57% to ₩177,700. The fair value is estimated to be ₩233,143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 117% in the next 2 years. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩188,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩232,865 per share. Valuation Update With 7 Day Price Move • May 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩160,500, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩184,606 per share. Buy Or Sell Opportunity • Apr 26
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 8.4% to ₩134,500. The fair value is estimated to be ₩111,627, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period. Buy Or Sell Opportunity • Apr 19
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 12% to ₩135,300. The fair value is estimated to be ₩110,546, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period. Major Estimate Revision • Nov 14
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩8,136 to ₩7,241 per share. Revenue forecast steady at ₩1.81b. Net income forecast to grow 232% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩163,533 unchanged from last update. Share price fell 12% to ₩121,300 over the past week. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩131,400, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩81,014 per share. Major Estimate Revision • Aug 12
Consensus EPS estimates increase by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from ₩1.79b to ₩1.84b. EPS estimate increased from ₩6,844 to ₩7,573 per share. Net income forecast to grow 625% next year vs 125% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩118,714 to ₩141,786. Share price rose 28% to ₩133,100 over the past week. Price Target Changed • Aug 11
Price target increased by 11% to ₩132,214 Up from ₩118,714, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of ₩133,100. Stock is up 97% over the past year. The company is forecast to post earnings per share of ₩6,982 for next year compared to ₩1,838 last year. Price Target Changed • Jul 22
Price target increased by 7.7% to ₩117,571 Up from ₩109,214, the current price target is an average from 14 analysts. New target price is 20% above last closing price of ₩98,000. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₩6,844 for next year compared to ₩1,838 last year. Price Target Changed • Jun 01
Price target increased by 8.2% to ₩108,143 Up from ₩99,917, the current price target is an average from 14 analysts. New target price is 33% above last closing price of ₩81,100. Stock is up 17% over the past year. The company is forecast to post earnings per share of ₩6,595 for next year compared to ₩1,838 last year. Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩87,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 6.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩89,945 per share. Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩71,400, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩141,805 per share. Reported Earnings • Mar 26
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: ₩1,838 (down from ₩6,944 in FY 2021). Revenue: ₩1.60t (flat on FY 2021). Net income: ₩20.8b (down 72% from FY 2021). Profit margin: 1.3% (down from 4.7% in FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Price Target Changed • Mar 11
Price target increased by 8.0% to ₩94,923 Up from ₩87,923, the current price target is an average from 13 analysts. New target price is 18% above last closing price of ₩80,400. Stock is down 6.0% over the past year. The company is forecast to post earnings per share of ₩3,984 for next year compared to ₩6,944 last year. Major Estimate Revision • Jan 27
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from ₩4,579 to ₩4,062 per share. Revenue forecast steady at ₩1.62b. Net income forecast to grow 26% next year vs 122% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩83,692 to ₩87,000. Share price rose 2.0% to ₩79,900 over the past week. Upcoming Dividend • Dec 21
Upcoming dividend of ₩550 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 07 April 2023. Payout ratio is a comfortable 12% but the company is paying out more than the cash it is generating. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%). Price Target Changed • Dec 14
Price target decreased to ₩75,692 Down from ₩81,571, the current price target is an average from 13 analysts. New target price is 13% above last closing price of ₩67,000. Stock is down 34% over the past year. The company is forecast to post earnings per share of ₩4,524 for next year compared to ₩6,944 last year. Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improved over the past week After last week's 16% share price gain to ₩67,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years. Major Estimate Revision • Nov 16
Consensus EPS estimates fall by 12% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.66b to ₩1.62b. EPS estimate also fell from ₩4,954 per share to ₩4,372 per share. Net income forecast to grow 20% next year vs 41% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩81,571 to ₩77,231. Share price rose 14% to ₩59,100 over the past week. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩42,550, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 39% over the past three years. Price Target Changed • Oct 12
Price target decreased to ₩93,357 Down from ₩101,286, the current price target is an average from 14 analysts. New target price is 114% above last closing price of ₩43,550. Stock is down 67% over the past year. The company is forecast to post earnings per share of ₩5,160 for next year compared to ₩6,944 last year. Price Target Changed • Oct 08
Price target decreased to ₩97,357 Down from ₩107,571, the current price target is an average from 14 analysts. New target price is 97% above last closing price of ₩49,450. Stock is down 63% over the past year. The company is forecast to post earnings per share of ₩5,187 for next year compared to ₩6,944 last year. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩51,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years. Price Target Changed • May 19
Price target decreased to ₩120,267 Down from ₩131,938, the current price target is an average from 15 analysts. New target price is 89% above last closing price of ₩63,800. Stock is down 47% over the past year. The company is forecast to post earnings per share of ₩5,492 for next year compared to ₩6,944 last year. Valuation Update With 7 Day Price Move • May 18
Investor sentiment deteriorated over the past week After last week's 19% share price decline to ₩63,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 41% over the past three years. Major Estimate Revision • May 17
Consensus EPS estimates fall by 37% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.75b to ₩1.68b. EPS estimate also fell from ₩7,613 per share to ₩4,790 per share. Net income forecast to shrink 25% next year vs 22% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩131,938 to ₩124,933. Share price fell 18% to ₩63,600 over the past week. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Price Target Changed • Mar 10
Price target decreased to ₩147,118 Down from ₩159,125, the current price target is an average from 17 analysts. New target price is 75% above last closing price of ₩83,900. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₩6,416 for next year compared to ₩2,128 last year. Buying Opportunity • Jan 19
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 43%. The fair value is estimated to be ₩93,653, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% per annum over the last 3 years. Earnings per share has grown by 12% per annum over the last 3 years. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩84,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩102,416 per share. Price Target Changed • Aug 15
Price target increased to ₩173,150 Up from ₩161,632, the current price target is an average from 19 analysts. New target price is 30% above last closing price of ₩133,000. Stock is up 16% over the past year. Tillkännagivande • Jun 26
Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion. Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,300,000
Price\Range: KRW 103000
Transaction Features: ESOP Related Offering; Rights Offering Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₩111,500, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩110,448 per share. 